Clinical value of new techniques of gynecological tumor assessment
作者： H. Fox
DOI: 10.1046/J.1525-1438.1997.00060.X
关键词: Cancer 、 Flow cytometry 、 Medicine 、 Lichen Sclerosis 、 Vulva 、 Cell growth 、 Pathology 、 Pathological 、 Hormone receptor 、 Clinical value 、 Oncology 、 Internal medicine
摘要: Fox H. Clinical value of new techniques gynecological tumor assessment.Int J Gynecol Cancer 1997; 7: 337–349. The clinical assessment tumorsis reviewed. These include flow cytometry, quantitative tissueanalysis, the detection ofsteroid hormone receptors, establishment cell proliferation indices, thestudy mutations in suppression genes, and examination theexpression oncogenes growth factors. It is concluded that none these has yet supplanted thetraditional pathological tumors. Only cytometry andmorphometry currently meritconsideration for routine adoption carefully defined situations.
sci-hub.se 参考文章(187)
Jolanta Kupryjańczyk, Debra A. Bell, David W. Yandell, Robert E. Scully, Ann D. Thor, p53 Expression in Ovarian Borderline Tumors and Stage I Carcinomas American Journal of Clinical Pathology. ,vol. 102, pp. 671- 676 ,(1994) , 10.1093/AJCP/102.5.671
Bouvous G, Elemental diets during cancer chemotherapy: a commentary. Anticancer Research. ,vol. 7, pp. 1225- ,(1987)
Joseph T. Chambers, Maria Luisa Carcangiu, Irene M. Voynick, Peter E. Schwartz, Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival. American Journal of Clinical Pathology. ,vol. 94, pp. 255- 260 ,(1990) , 10.1093/AJCP/94.3.255
J Bourhis, M G Le, M Barrois, A Gerbaulet, D Jeannel, P Duvillard, V Le Doussal, D Chassagne, G Riou, Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. Journal of Clinical Oncology. ,vol. 8, pp. 1789- 1796 ,(1990) , 10.1200/JCO.1990.8.11.1789
DJ Cole, DC Brown, E Crossley, CJ Alcock, KC Gatter, Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. British Journal of Cancer. ,vol. 65, pp. 783- 785 ,(1992) , 10.1038/BJC.1992.167
J. Kupryjanczyk, A. D. Thor, R. Beauchamp, V. Merritt, S. M. Edgerton, D. A. Bell, D. W. Yandell, p53 gene mutations and protein accumulation in human ovarian cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 4961- 4965 ,(1993) , 10.1073/PNAS.90.11.4961
Yuji Yaginuma, Kohki Yamashita, Noboru Kuzumaki, Masahiro Fujita, Tetsuya Shimizu, ras oncogene product p21 expression and prognosis of human ovarian tumors. Gynecologic Oncology. ,vol. 46, pp. 45- 50 ,(1992) , 10.1016/0090-8258(92)90194-N
B. Sorbe, B. Risberg, Prognostic importance of the nuclear proteins p53 and Rb in conjunction with DNA, nuclear morphometry and grading in endometrial carcinoma. International Journal of Gynecological Cancer. ,vol. 7, pp. 34- 41 ,(1997) , 10.1046/J.1525-1438.1997.00416.X
William T. Creasman, John T. Soper, Kenneth S. McCarty, Kenneth S. McCarty, Wanda Hinshaw, Daniel L. Clarke-Pearson, Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. American Journal of Obstetrics and Gynecology. ,vol. 151, pp. 922- 932 ,(1985) , 10.1016/0002-9378(85)90671-4
L.A. Allan, M.K. Campbell, B.J. Milner, D.M. Eccles, R.C.F. Leonard, D.E. Parkin, I.D. Miller, A.M. Lessells, H.C. Kitchener, N.E. Haites, The significance of p53 mutation and over‐expression in ovarian cancer prognosis International Journal of Gynecological Cancer. ,vol. 6, pp. 483- 490 ,(1996) , 10.1046/J.1525-1438.1996.06060483.X